All In Biotech

Drug Trial Radar · NCT00064753

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

Last checked: Nov 19, 2026Latest source record: Oct 18, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 4,110 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

4,110

Actual

Start

May 2002

Primary completion

Oct 2011

Study completion Oct 2011

Sponsor

Sponsor type
NIH
Collaborators
Office of Dietary Supplements (ODS)
First posted
Jul 15, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 35 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this randomized clinical trial is to determine if lowering homocysteine levels in renal transplant recipients with a multivitamin will reduce the occurrence of cardiovascular disease outcomes.

Conditions

  • Chronic Kidney Disease
  • Cardiovascular Disease
  • Death

Interventions

  • High Dose MultivitaminDrug

    Vitamin B6 (Pyridoxine HCl): 50 mg Folic acid: 5.0 mg Vitamin B12: 1.0 mg Vitamin B1 (Thiamine HNO3): 1.5 mg Vitamin B2 (Riboflavin): 1.5 mg Vitamin C (Ascorbic Acid): 60 mg d-Biotin: 300 mcg Niacinamide: 20 mg Pantothenic Acid Calcium Pantothenate): 10 mg

  • Low Dose MultivitaminDevice

    Vitamin B6 (Pyridoxine HCl): 1.4 mg Folic acid: 0.0 mg Vitamin B12: 2.0 mcg Vitamin B1 (Thiamine HNO3): 1.5 mg Vitamin B2 (Riboflavin): 1.5 mg Vitamin C (Ascorbic Acid): 60 mg d-Biotin: 300 mcg Niacinamide: 20 mg Pantothenic Acid Calcium Pantothenate): 10 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Recurrent or de Novo Arteriosclerotic Cardiovascular Disease (CVD) Defined as the Occurrence of Non-fatal or Fatal Arteriosclerotic Outcomes Including Coronary Heart, Cerebrovascular, and Peripheral Vascular Disease EventsTime frame: Up to 6 years (mean 4 years)

Locations

30 sites in 3 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham School of Medicine

    Birmingham, Alabama

  • Banner Good Samaritan Transplant

    Phoenix, Arizona

  • Cedars-Sinai Health System/Center for Kidney Diseases and Transplantation

    Los Angeles, California

  • University of California at Los Angeles

    Los Angeles, California

  • University of California at San Francisco

    San Francisco, California

  • Northwestern University

    Chicago, Illinois

  • Southern Illinois University

    Springfield, Illinois

  • Indiana University

    Indianapolis, Indiana

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • Maine Medical Center

    Portland, Maine

  • University of Maryland Medical Center

    Baltimore, Maryland

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • University of Michigan Medical Center

    Ann Arbor, Michigan

  • Hennepin County Medical Center

    Minneapolis, Minnesota

  • Faireview University Medical Center

    Minneapolis, Minnesota

  • Mayo Clinic

    Rochester, Minnesota

  • Washington University

    St Louis, Missouri

  • Albany Medical Center

    Albany, New York

  • State University of New York Downstate Medical Center

    Brooklyn, New York

  • Duke University Medical Center

    Durham, North Carolina

  • East Carolina University

    Greenville, North Carolina

  • The Ohio State University Medical Center

    Columbus, Ohio

  • Oregon Health Sciences University

    Portland, Oregon

  • Drexel University

    Philadelphia, Pennsylvania

  • Rhode Island Hospital

    Providence, Rhode Island

  • University of Wisconsin at Madison

    Madison, Wisconsin

  • Medical College of Wisconsin

    Milwaukee, Wisconsin

  • Universidade Federal de Sao Paulo

    São Paulo, São Paulo, Brazil

  • London Health Sciences Center

    London, Ontario, Canada

  • Toronto General Hospital

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.